|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||13.82 - 14.55|
|52 Week Range||9.66 - 15.40|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ringing today's closing bells are Ignacio Cueto, chairman of the board at LATAM Airlines Group S.A., at the NYSE and Ankit Mahadevia, MD, Spero Therapeutics president and CEO, at the Nasdaq.
Today I will take a look at Spero Therapeutics Inc’s (NASDAQ:SPRO) most recent earnings update (30 June 2017) and compare these latest figures against its performance over the past fewRead More...